Search

Your search keyword '"Shayanrad A"' showing total 190 results

Search Constraints

Start Over You searched for: Author "Shayanrad A" Remove constraint Author: "Shayanrad A"
190 results on '"Shayanrad A"'

Search Results

1. General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants

2. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

4. Prevalence, awareness, treatment, and control of hypertension based on ACC/AHA versus JNC7 guidelines in the PERSIAN cohort study

5. Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study

6. Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study

7. Prevalence, awareness, treatment, and control of hypertension based on ACC/AHA versus JNC7 guidelines in the PERSIAN cohort study

8. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

9. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study

10. Metabolomics reveals biomarkers of opioid use disorder

11. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran

12. Prevalence and determinants of anemia among Iranian population aged ≥35 years: A PERSIAN cohort–based cross-sectional study

13. Dynamics of the COVID-19 Clinical Findings and the Serologic Response

14. Metabolomics reveals biomarkers of opioid use disorder

21. Untargeted Metabolomics: Biochemical Perturbations in Golestan Cohort Study Opium Users Inform Intervention Strategies

22. Colorectal cancer and the KIR genes in the human genome: A meta-analysis

23. Diminishing benefits of urban living for children and adolescents’ growth and development

24. Cohort Profile: The Urmia Lake Cohort Study (ULCS)

26. Investigation of Durability of SARS-CoV-2-specific IgG and IgM Antibodies in Recovered COVID-19 Patients: A Prospective Study

27. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

29. Investigation of Durability of SARS-CoV-2-specific IgG and IgM Antibodies in Recovered COVID-19 Patients: A Prospective Study

30. Metabolomics reveals biomarkers of opioid use disorder

31. Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants

32. Cohort Profile: The Urmia Lake Cohort Study (ULCS)

33. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran

34. All-Cause and Cause-Specific Mortality in Middle-Aged Individuals with Positive HBsAg: Findings from a Prospective Cohort Study

35. The Khuzestan Comprehensive Health Study (KCHS): Methodology and Profile of Participants

36. Effect of Storage Temperature and Time on Stability of Liver Enzymes in Blood Serum

37. Additional file 1 of Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study

38. Prevalence and determinants of anemia among Iranian population aged ≥35 years: A PERSIAN cohort–based cross-sectional study

39. Lead poisoning among asymptomatic individuals with a long-term history of opiate use in Golestan Cohort Study

41. Prevalence and determinants of anemia among Iranian population aged ≥35 years: A PERSIAN cohort-based cross-sectional study

42. SARS-COV-2 Seroprevalence among Health Care Workers in Private and Public Hospitals in Tehran, Iran

43. Dynamics of the COVID-19 Clinical Findings and the Serologic Response

44. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study

45. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight NCD Risk Factor Collaboration (NCD-RisC)

46. SARS-COV-2 Seroprevalence among Health Care Workers in Private and Public Hospitals in Tehran, Iran

47. Prevalence, Awareness, Treatment, and Control of Hypertension in the PERSIAN Cohort Study: JNC7 Versus ACC/AHA Guidelines Short Title: The Impacts of Hypertension Definition in Iran

48. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

49. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

50. Author response: Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

Catalog

Books, media, physical & digital resources